Filter announcements
Loading...
Morepen Laboratories Ltd is engaged in the business of manufacturing, producing, developing and marketing a wide range of Active Pharmaceutical Ingredients (APIs), branded and generic formulations and also the Home Health products.
Morepen Labs secured an international CDMO contract worth ₹825 Cr from a leading global pharma major. This commercial supply deal is expected to be executed over approximately 12-15 months.